BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,771,440 | -5.3% | 46,938 | +14.3% | 0.01% | 0.0% |
| Q2 2023 | $1,870,739 | +32.7% | 41,061 | +18.1% | 0.01% | +25.0% |
| Q1 2023 | $1,409,825 | -70.5% | 34,759 | -62.9% | 0.00% | -66.7% |
| Q4 2022 | $4,771,811 | +59.0% | 93,620 | +68.0% | 0.01% | +20.0% |
| Q3 2022 | $3,002,000 | -69.2% | 55,740 | -63.3% | 0.01% | -56.5% |
| Q2 2022 | $9,754,000 | -60.7% | 151,846 | -52.6% | 0.02% | -45.2% |
| Q1 2022 | $24,843,000 | -58.5% | 320,386 | -54.1% | 0.04% | -50.0% |
| Q4 2021 | $59,861,000 | -31.0% | 697,339 | -35.3% | 0.08% | -45.1% |
| Q3 2021 | $86,704,000 | +43.4% | 1,077,998 | +43.5% | 0.15% | +37.8% |
| Q2 2021 | $60,479,000 | -6.3% | 751,282 | -1.8% | 0.11% | -11.9% |
| Q1 2021 | $64,539,000 | +79.5% | 765,224 | +70.7% | 0.13% | +65.8% |
| Q4 2020 | $35,961,000 | -9.0% | 448,169 | -8.8% | 0.08% | -29.0% |
| Q3 2020 | $39,518,000 | -67.7% | 491,390 | -67.4% | 0.11% | -74.5% |
| Q1 2020 | $122,325,000 | +1251.7% | 1,506,664 | +1292.1% | 0.42% | +1809.1% |
| Q4 2019 | $9,050,000 | -36.7% | 108,231 | -33.7% | 0.02% | -47.6% |
| Q3 2019 | $14,290,000 | +14.3% | 163,367 | +7.0% | 0.04% | -19.2% |
| Q2 2019 | $12,507,000 | -1.0% | 152,705 | -1.7% | 0.05% | +4.0% |
| Q1 2019 | $12,629,000 | +81.0% | 155,310 | +46.5% | 0.05% | +51.5% |
| Q4 2018 | $6,978,000 | -53.6% | 106,018 | -45.7% | 0.03% | -50.7% |
| Q3 2018 | $15,034,000 | +1.8% | 195,088 | -2.5% | 0.07% | -17.3% |
| Q2 2018 | $14,770,000 | +6.1% | 200,028 | -6.6% | 0.08% | +12.5% |
| Q1 2018 | $13,919,000 | -68.3% | 214,050 | -68.5% | 0.07% | -64.0% |
| Q4 2017 | $43,911,000 | +154.6% | 679,324 | +147.1% | 0.20% | +98.0% |
| Q3 2017 | $17,248,000 | -6.7% | 274,873 | -10.0% | 0.10% | +4.1% |
| Q2 2017 | $18,494,000 | -46.6% | 305,502 | -54.3% | 0.10% | -34.5% |
| Q1 2017 | $34,646,000 | +123.4% | 668,074 | +91.0% | 0.15% | +87.3% |
| Q4 2016 | $15,507,000 | -61.3% | 349,731 | -58.4% | 0.08% | -65.2% |
| Q3 2016 | $40,050,000 | -17.0% | 841,369 | -21.2% | 0.23% | -20.1% |
| Q2 2016 | $48,271,000 | +11365.8% | 1,067,479 | +10327.7% | 0.28% | +9366.7% |
| Q1 2016 | $421,000 | +9.4% | 10,237 | +1.4% | 0.00% | +50.0% |
| Q4 2015 | $385,000 | +16.7% | 10,097 | +0.4% | 0.00% | 0.0% |
| Q3 2015 | $330,000 | -98.6% | 10,057 | -97.1% | 0.00% | -98.3% |
| Q2 2015 | $24,227,000 | +3.3% | 346,642 | +1.3% | 0.12% | +14.3% |
| Q1 2015 | $23,451,000 | -6.5% | 342,337 | +0.1% | 0.10% | +9.4% |
| Q4 2014 | $25,076,000 | +11.3% | 342,137 | +9.0% | 0.10% | +5.5% |
| Q3 2014 | $22,524,000 | -0.6% | 313,837 | +0.1% | 0.09% | -2.2% |
| Q2 2014 | $22,658,000 | -1.6% | 313,384 | +0.1% | 0.09% | -3.1% |
| Q1 2014 | $23,037,000 | +21.5% | 313,087 | +14.8% | 0.10% | +20.0% |
| Q4 2013 | $18,962,000 | +3917.4% | 272,638 | +3690.9% | 0.08% | +3900.0% |
| Q3 2013 | $472,000 | -11.3% | 7,192 | -6.5% | 0.00% | -33.3% |
| Q2 2013 | $532,000 | -2.9% | 7,690 | +1.9% | 0.00% | 0.0% |
| Q1 2013 | $548,000 | – | 7,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |